Venus Remedies developing new cancer drug delivery technology
Venus Remedies is developing a new drug delivery platform that promises to reduce side effects and cost of cancer medicine by as much as one-sixth.
NEW DELHI: Venus Remedies is developing a new drug delivery platform that promises to reduce side effects and cost of cancer medicine by as much as one-sixth.
The company has designed a new drug delivery technology, drug protein polymer conjugate, that has been found to deliver cancer drug at the targeted (affected) organ for breast and ovarian cancer during pre-clinical studies, Mufti Suhail Sayeed, VP at Venus Remedies Research Centre said. The patented platform will enable a patient to reduce intake of drug by 4-6 times, thus reducing the toxicity level and cost of medicine.
The company believes the technology can be used to treat all forms of solid tumours and will soon start clinical studies to check the same. The Chandigarh-based drug company plans to launch the technology in the next 2-3 years. It plans to rope in a partner for the clinical studies and is also open monetizing the technology.
The company's share price closed marginally down at Rs 164 at the Bombay Stock Exchange on Monday.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
